Ailux Biologics Forges License Deal with Janssen Biotech on Biologics AI Platform
Under the agreement, Ailux Biologics grants Janssen and its affiliates a non-exclusive license to leverage its XtalFold platform for the discovery and engineering of biologics.
Janssen Biotech | 14/10/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy